| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3168620 | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology | 2008 | 7 Pages |
Abstract
Local immunosuppressive therapies without systemic effects represent a therapeutic advantage in management of immune/inflammatory oral mucosal conditions. Topical budesonide rinses were prescribed to patients with mucosal disease that was resistant to other intervention without side effects. A case of paraneoplastic pemphigus and a patient with oral graft-versus-host disease that had not responded to standard approaches to management were successfully managed with budesonide rinse application. The cases presented represent mucosal conditions that were successfully managed with topical application of budesonide with reduced risk of systemic effects.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Robert A. Utsman, Joel B. Epstein, Sharon Elad,